This achievement was attributed to the encapsulation of DOX and indocyanine green (ICG)‐loaded hollow CuS NPs in the melanoma cell membrane.[38] Alternatively, sorafenib, anti‐VEGFR antibodies, and hollow CuS NPs could be encased in tumor cell/macrophage hybrid membranes, improving the targeting capability and internalization in tumor cells, and leading to synergistic chemo/PTT. Here, KDR is linked to neoplasm.